RhoDx: Todd Druley

RhoDx, a St. Louis-based developer of cancer early detection tests, has appointed Todd Druley as an advisor. Druley was recently named chief medical officer at Angle, and previously served as CMO at ArcherDx prior to its acquisition by Invitae in October 2020. He is an associate professor of pediatric hematology and oncology, developmental biology, and genetics at Washington University School of Medicine in St. Louis, an inductee into the American Society of Clinical Investigators, and a scientific advisor for the B+ Foundation and the Eli Seth Matthews Leukemia Foundation.